Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Cellectar Biosciences, Inc.
Baylor College of Medicine
Essen Biotech
Brigham and Women's Hospital
St. Jude Children's Research Hospital
Institut Bergonié
Duke University
OncoNano Medicine, Inc.
National Cancer Institute (NCI)
Cancer Research UK
St. Jude Children's Research Hospital
Incyte Corporation
Washington University School of Medicine
Trishula Therapeutics, Inc.
Novartis
University Health Network, Toronto
RenJi Hospital
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
RAPT Therapeutics, Inc.
Cedars-Sinai Medical Center
University of Virginia
Association Francaise pour la Recherche Thermale
Haukeland University Hospital
Huashan Hospital
Rutgers, The State University of New Jersey
City of Hope Medical Center
Eastern Cooperative Oncology Group
Fate Therapeutics
Sierra Oncology LLC - a GSK company
Blue Note Therapeutics
Incyte Corporation
Celgene
University of South Florida
AstraZeneca
Institut Bergonié
MultiVir, Inc.
Masonic Cancer Center, University of Minnesota
Celgene
Tocagen Inc.
Acrotech Biopharma Inc.
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Shenzhen BinDeBio Ltd.
Tel-Aviv Sourasky Medical Center
University of Southern California
University of Chicago